Search Results

You are looking at 1 - 4 of 4 items for

  • Author: R Ivell x
  • Refine by access: All content x
Clear All Modify Search
R Ivell
Search for other papers by R Ivell in
Google Scholar
PubMed
Close
Free access
H Ungefroren
Search for other papers by H Ungefroren in
Google Scholar
PubMed
Close
,
M Davidoff
Search for other papers by M Davidoff in
Google Scholar
PubMed
Close
, and
R Ivell
Search for other papers by R Ivell in
Google Scholar
PubMed
Close

Abstract

Northern blot hybridization showed that bovine and sheep testis, unlike testes from other mammals, contain moderate levels of an apparently normal oxytocin gene transcript. In situ hybridization localized this mRNA to within the seminiferous tubules, possibly in the Sertoli cells. Conflicting with this result, immunohistochemistry showed that both oxytocin and the syngeneic neurophysin I epitopes are both clearly restricted to the Leydig cells, being expressed here at a low level. Since illegitimate transcription from spurious start sites can lead to a lack of translation product, the integrity of the major ruminant testicular transcripts of the oxytocin gene was checked using differential hybridization, RNase protection and multiple polymerase chain reaction assays. All tests showed the transcripts to have a normal, translatable composition and to be transcribed from the conventional 5' initiation site. Therefore, the block in oxytocin gene expression within the tubules is probably due to a lesion at the post-transcriptional level. The low level peptide expression in the Leydig cells can probably be attributed to the presence of functional transcripts in these cells, which are below the level of significant detection for the in situ hybridization assay.

Journal of Endocrinology (1994) 140, 63–72

Restricted access
K. P. Willey
Search for other papers by K. P. Willey in
Google Scholar
PubMed
Close
,
N. Hunt
Search for other papers by N. Hunt in
Google Scholar
PubMed
Close
,
N. Abend
Search for other papers by N. Abend in
Google Scholar
PubMed
Close
,
W. Northemann
Search for other papers by W. Northemann in
Google Scholar
PubMed
Close
,
R. Ivell
Search for other papers by R. Ivell in
Google Scholar
PubMed
Close
, and
F. Leidenberger
Search for other papers by F. Leidenberger in
Google Scholar
PubMed
Close

ABSTRACT

A specific homologous radioligand receptor assay for thyroid-stimulating hormone (TSH) using bovine thyroid membranes was adapted for use with human thyroid. Specific 125I-labelled TSH binding was detected in the 3000 g membrane pellet from bovine thyroid but predominantly in the 3000 g supernatant of the human thyroid homogenate. Both assays required incubation in the presence of 10% serum, whilst the assay using human thyroid could only be precipitated using polyethylene glycol (PEG). The serum requirement transcended a possible role as carrier protein and unmasked specific TSH binding. Molecular sieving determined that the active fraction of the serum had an apparent size of 30 000–100 000. The requirement for PEG-assisted precipitation of the TSH receptor assay was a consequence of the TSHbinding entity from Graves' thyroid behaving like a soluble 'receptor': it did not sediment with the membranes, passed a 0·2 μm filter and, upon molecular sieving, had an apparent size of 300 000–1 000 000. A full-length TSH receptor cDNA was cloned from a human Graves' thyroid library and stably transfected cell lines expressing the TSH-receptor protein were constructed using human HeLa and murine 3T3 cells. Specific TSH binding was unmasked by serum in the human cell lines, as observed for the human thyroid TSH receptor, whereas serum hindered TSH binding in the murine cell lines. A soluble form of the receptor was not released from the cells and was not produced in conditions which demonstrated a soluble receptor-like binding component in human thyroid tissue.

Journal of Endocrinology (1993) 139, 317–328

Restricted access
H-L Ang
Search for other papers by H-L Ang in
Google Scholar
PubMed
Close
,
R Ivell
Search for other papers by R Ivell in
Google Scholar
PubMed
Close
,
N Walther
Search for other papers by N Walther in
Google Scholar
PubMed
Close
,
H Nicholson
Search for other papers by H Nicholson in
Google Scholar
PubMed
Close
,
H Ungefroren
Search for other papers by H Ungefroren in
Google Scholar
PubMed
Close
,
M Millar
Search for other papers by M Millar in
Google Scholar
PubMed
Close
,
D Carter
Search for other papers by D Carter in
Google Scholar
PubMed
Close
, and
D Murphy
Search for other papers by D Murphy in
Google Scholar
PubMed
Close

Abstract

The bovine oxytocin gene has been expressed in the testes of two independent transgenic mouse lines. Hybridization and RNase protection analysis showed that the oxytocin transgene was transcribed from the normal functional promoter in the Sertoli cells of the seminiferous tubules in a developmentally regulated manner. Immunohistochemistry indicated that both oxytocin and neurophysin epitopes were expressed together in the Sertoli cells at stages I–V and X–XII of the cycle of the seminiferous epithelium. Furthermore, analysis with high- performance liquid chromatography showed that there was a tenfold increase in the amount of amidated oxytocin present in testicular extracts from the transgenic mice. However, there appeared to be no detectable effect of this overproduction of hormone on testicular morphology or fertility parameters. A significant decrease by 50% was detected only in the levels of intratesticular testosterone and dihydrotestosterone. The results point to a local paracrine role for oxytocin in the modulation of Leydig cell function.

Journal of Endocrinology (1994) 140, 53–62

Restricted access